Swedbank AB Trims Stock Holdings in The Cooper Companies, Inc. $COO

Swedbank AB lowered its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 23.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 819,229 shares of the medical device company’s stock after selling 254,800 shares during the quarter. Swedbank AB owned about 0.42% of Cooper Companies worth $58,575,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. Root Financial Partners LLC lifted its holdings in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the last quarter. SJS Investment Consulting Inc. increased its holdings in Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares during the last quarter. Bell Investment Advisors Inc raised its position in Cooper Companies by 106.3% in the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 219 shares during the period. CYBER HORNET ETFs LLC purchased a new stake in Cooper Companies in the second quarter valued at approximately $36,000. Finally, True Wealth Design LLC lifted its stake in Cooper Companies by 484.8% during the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $71.89 on Wednesday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The company has a market cap of $14.02 billion, a price-to-earnings ratio of 60.92, a price-to-earnings-growth ratio of 1.90 and a beta of 0.84. The stock’s 50-day moving average is $64.81 and its two-hundred day moving average is $73.18. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter last year, the business posted $0.96 EPS. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of research reports. Mizuho set a $85.00 price objective on Cooper Companies and gave the company an “outperform” rating in a research note on Thursday, June 4th. The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a research note on Wednesday, May 27th. Robert W. Baird lowered their target price on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, June 5th. Citigroup reaffirmed a “neutral” rating and issued a $69.00 target price (down from $80.00) on shares of Cooper Companies in a research report on Thursday, May 28th. Finally, Wells Fargo & Company reiterated a “sell” rating and set a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $81.31.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.